Sabal Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$2.18M Sell
30,139
-40
-0.1% -$2.9K 0.12% 98
2024
Q4
$2.23M Sell
30,179
-6,851
-19% -$507K 0.13% 100
2024
Q3
$2.44M Buy
37,030
+14,311
+63% +$944K 0.13% 91
2024
Q2
$2.1M Sell
22,719
-8,934
-28% -$825K 0.12% 85
2024
Q1
$3.02M Sell
31,653
-34
-0.1% -$3.25K 0.18% 73
2023
Q4
$2.42M Buy
31,687
+5
+0% +$381 0.15% 73
2023
Q3
$2.19M Buy
31,682
+1,899
+6% +$132K 0.15% 71
2023
Q2
$2.81M Buy
29,783
+20,792
+231% +$1.96M 0.18% 65
2023
Q1
$744K Buy
8,991
+90
+1% +$7.45K 0.05% 80
2022
Q4
$664K Sell
8,901
-18
-0.2% -$1.34K 0.05% 87
2022
Q3
$737K Sell
8,919
-137
-2% -$11.3K 0.06% 82
2022
Q2
$861K Buy
9,056
+33
+0.4% +$3.14K 0.06% 76
2022
Q1
$1.06M Buy
9,023
+141
+2% +$16.6K 0.07% 71
2021
Q4
$1.15M Hold
8,882
0.07% 74
2021
Q3
$1.01M Hold
8,882
0.07% 75
2021
Q2
$920K Sell
8,882
-91
-1% -$9.43K 0.07% 76
2021
Q1
$751K Buy
8,973
+82
+0.9% +$6.86K 0.06% 85
2020
Q4
$811K Buy
8,891
+131
+1% +$11.9K 0.07% 78
2020
Q3
$699K Hold
8,760
0.06% 79
2020
Q2
$605K Hold
8,760
0.06% 79
2020
Q1
$551K Hold
8,760
0.06% 79
2019
Q4
$681K Hold
8,760
0.05% 85
2019
Q3
$642K Hold
8,760
0.05% 87
2019
Q2
$539K Hold
8,760
0.05% 88
2019
Q1
$559K Hold
8,760
0.05% 89
2018
Q4
$447K Hold
8,760
0.05% 96
2018
Q3
$508K Hold
8,760
0.04% 100
2018
Q2
$425K Hold
8,760
0.04% 105
2018
Q1
$407K Hold
8,760
0.04% 109
2017
Q4
$329K Hold
8,760
0.03% 104
2017
Q3
$319K Sell
8,760
-42
-0.5% -$1.53K 0.03% 109
2017
Q2
$347K Buy
8,802
+42
+0.5% +$1.66K 0.04% 105
2017
Q1
$275K Buy
+8,760
New +$275K 0.03% 112